eClinical Tech News

ProQR Therapeutics will rotate co-founder Dinko Valerio and director Alison Lawton off its board at the company’s 2026 annual...

BioSyent is acquiring Oral Science, a Canadian dental-focused distributor, for $25.5 million in cash and stock, with additional contingent...

Memo Therapeutics has signed a strategic collaboration and exclusive option-to-license agreement with CSL to advance recombinant polyclonal IgG products...

Inotiv posted first-quarter fiscal 2026 revenue of $120.9 million, up 0.8% year over year, as double‑digit growth in Discovery...

Denali Therapeutics unveiled new data across its lysosomal storage disorder portfolio and confirmed commercial readiness ahead of an April...

Ocular Therapeutix will unveil 52-week topline data from SOL-1, its Phase 3 superiority trial of the intravitreal axitinib hydrogel...

Tiziana Life Sciences’ intranasal foralumab has cleared an important credibility hurdle with the peer-reviewed publication of its open-label study...

Ascendis Pharma will report full-year 2025 results and host a business update on February 11, 2026, after the U.S....

HighLife has secured CE Mark approval for its transfemoral Transcatheter Mitral Valve Replacement system, enabling initial commercial availability across...

NMD Pharma reported topline Phase 2a results for ignaseclant in Charcot‑Marie‑Tooth disease (CMT) showing the study did not meet...